Success Stories: Our Team at NAILG Helps a Scientist from Hong Kong Working in Organic Chemistry Win NIW Approval Quickly
Client’s Testimonial:
“Thank you NAILG! They are professional and passionate for helping me to go through this campaign! I truly appreciate the high quality of documental service provided by the team of attorneys, as well as their prompt and clear response.”
On April 23rd, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Organic Chemistry (Approval Notice).
General Field: Organic Chemistry
Position at the Time of Case Filing: Scientist
Country of Origin: Hong Kong
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: April 23rd, 2022
Processing Time: 2 months, 20 days
Case Summary:
As an expert in the field of organic chemistry, our NIW (National Interest Waiver) client’s proposed endeavor was to continue his research on developing and improving oncology and neurology drugs and treatment methods for improved global public health outcomes. This meant that his work was of immense value to the country. Our attorney helped him understand that as an NIW applicant, his work was to prove how his research was valuable for the United States. And this is exactly what our firm and attorney would help him with.
As soon as the formality of signing the retainer was over, we began building a strong database of his accomplishments thus far and found:
- Due to its clear national importance, his research has in fact been supported with funding from 4 well-known national and international institutions of higher learning and research.
- He has completed at least 5 reviews to date for national and international scientific journals of repute in his field of study.
- His research has resulted in 4 peer-reviewed journal articles (all of them first-authored) and 1 patent in preparation.
- These publications have been cited a total of 92 times according to Google Scholar.
- He has also pursued research directly related to his proposed endeavor of developing and improving oncology and neurology drugs for 7 years now.
- We noted that his research into validating new therapeutic targets and developing new treatments will continue to be circulated to others in the field through the publication of papers in peer-reviewed journals and conferences.
- His research is relevant and his proposed endeavor is of great importance because it contributes to the development of improved molecular treatments for a variety of prominent diseases and disorders, including cancer.
- We also attached detailed descriptions of 4 of his key projects as evidence of his contributions to and expertise in the field of organic chemistry.
- Finally, we also made sure to attach letters of recommendation from 2 experts who vouched for his work’s relevance and the importance of his contributions.